Research Type: Extramural
A/Professor Wang and her team will develop a test to monitor treatment response and watch for the early signs of treatment failure.
Dr Blancafort and her team will develop a test to detect a gene prolific in aggressive forms of breast cancer and identify new treatment targets.
Prof Price is investigating how new imaging technology could be used to enhance radiotherapy effectiveness in solid cancers.
A/Prof Griffin will conduct pre-clinical tests of a much needed new combination treatment for patients with advanced pancreatic and bowel cancers.
Dr Cheung’s project will be the first to identify and investigate the risk factors for the development of some childhood cancers.
This research will pave the way for the development of a less invasive and personalised diagnostic tests to detect cancer relapse in children with ALL.
A/Prof Buchanan and his team will determine how the gut bacteria causes bowel cancer in younger adults by looking at samples.
Alongside a clinical trial of ribociclib for prostate cancer, Professor Butler and her team will identify biomarkers that can be used to identify which patients this new drug is likely to benefit.
Researchers will test a more targeted treatment approach in greatly improving outcomes for individual children with advanced neuroblastoma.
Researchers will use cutting-edge imaging technology and lab models that mimic pancreatic cancer and watch tumour response to treatment.